3D iPSC-derived neuromuscular organoid with myofibers labeled by phalloidin (red), neurons marked by β3-tubulin (green), and nuclei stained with Hoechst (blue). Multicellular 3D iPSC-derived neuromuscular organoid enables disease modelling and therapeutic testing Captured by fluorescence microscopy at 20x.
3D iPSC-derived neuromuscular organoid with myofibers labeled by phalloidin (red), neurons marked by β3-tubulin (green), and nuclei stained with Hoechst (blue). Multicellular 3D iPSC-derived neuromuscular organoid enables disease modelling and therapeutic testing Captured by fluorescence microscopy at 20x.
3D iPSC-derived neuromuscular organoid with myofibers labeled by phalloidin (red), neurons marked by β3-tubulin (green), and nuclei stained with Hoechst (blue). Multicellular 3D iPSC-derived neuromuscular organoid enables disease modelling and therapeutic testing Captured by fluorescence microscopy at 20x.
3D iPSC-derived neuromuscular organoid with myofibers labeled by phalloidin (red), neurons marked by β3-tubulin (green), and nuclei stained with Hoechst (blue). Multicellular 3D iPSC-derived neuromuscular organoid enables disease modelling and therapeutic testing Captured by fluorescence microscopy at 20x.
3D iPSC-derived neuromuscular organoid with myofibers labeled by phalloidin (red), neurons marked by β3-tubulin (green), and nuclei stained with Hoechst (blue). Multicellular 3D iPSC-derived neuromuscular organoid enables disease modelling and therapeutic testing Captured by fluorescence microscopy at 20x.
